PointCare Technologies
Founded Year
2002Stage
Unattributed VC - II | AliveTotal Raised
$5.4MLast Raised
$1.8M | 12 yrs agoMissing: PointCare Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: PointCare Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
PointCare Technologies Patents
PointCare Technologies has filed 2 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/30/2007 | 11/18/2014 | Immunology, Clusters of differentiation, Immune system, Flow cytometry, G protein coupled receptors | Grant |
Application Date | 1/30/2007 |
|---|---|
Grant Date | 11/18/2014 |
Title | |
Related Topics | Immunology, Clusters of differentiation, Immune system, Flow cytometry, G protein coupled receptors |
Status | Grant |
PointCare Technologies Frequently Asked Questions (FAQ)
When was PointCare Technologies founded?
PointCare Technologies was founded in 2002.
Where is PointCare Technologies's headquarters?
PointCare Technologies's headquarters is located at 257 Simarano Drive, Marlborough.
What is PointCare Technologies's latest funding round?
PointCare Technologies's latest funding round is Unattributed VC - II.
How much did PointCare Technologies raise?
PointCare Technologies raised a total of $5.4M.
Who are the investors of PointCare Technologies?
Investors of PointCare Technologies include 424 Capital.
Who are PointCare Technologies's competitors?
Competitors of PointCare Technologies include Innara Health, MedShape, Intellirod Spine, Epocal, Minomic International and 15 more.
Compare PointCare Technologies to Competitors
SPOC is a provider of a diagnostic medical device that identifies the specific myofacial (muscle) trigger points that SPOC says are often overlooked by conventional diagnosis which can cause neck and back pain. This device together with the patented clinical methodology developed by Dr. Norman Marcus, SPOC's chief medical officer and engaged in pain management, aim to provide a complete diagnostic package for accurate and precise identification of muscle pain.
NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.
MND Diagnostics is a healthcare company focused on disease diagnosis. The medical device company has developed a diagnostic detection platform which aims to be rapid, low-priced and portable.
Cord Blood Registry (CBR) is a newborn stem cell company. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today.
Sensys Medical develops medical diagnostic instruments
AndroDx (Andro Diagnostics) is a medical device maker focused on making more accurate diagnostic tests for prostate cancer.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.